Joanna Moncrieff
Overview
Explore the profile of Joanna Moncrieff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marston L, Moncrieff J, Priebe S, Cro S, Cornelius V
J Clin Epidemiol
. 2025 Mar;
:111753.
PMID: 40057141
Objective: Many trials are affected by unforeseen events after recruitment has commenced. The aim of this study is to explore a hypothetical strategy for dealing with an intercurrent event that...
2.
Siddiqui F, Petersen J, Juul S, Kamp C, Barbateskovic M, Moncrieff J, et al.
BMJ Open
. 2025 Feb;
15(2):e082853.
PMID: 39920066
Objectives: To assess the beneficial and harmful effects of duloxetine versus 'active placebo', placebo or no intervention for adults with major depressive disorder. Design: Systematic review with meta-analysis and trial...
3.
Kamp C, Petersen J, Faltermeier P, Juul S, Sillassen C, Siddiqui F, et al.
BMC Psychiatry
. 2025 Jan;
25(1):67.
PMID: 39844067
Background: Mirtazapine is used to treat depression worldwide, and the effects of mirtazapine on depression rating scales are well-known. Our primary objective was to assess the risks of adverse events...
4.
Bray G, Moncrieff J, Priebe S, Marston L, Lewis G, Haynes N, et al.
Value Health
. 2024 Aug;
28(3):358-367.
PMID: 39127250
Objectives: The current recommended treatment for patients with recurrent episodes of schizophrenia and related conditions is antipsychotic medication. However, many antipsychotic users remain functionally impaired and experience serious physical and...
5.
Kamp C, Petersen J, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M, et al.
BMJ Ment Health
. 2024 Aug;
27(1.
PMID: 39093721
Question: Tricyclic antidepressants are used to treat depression worldwide, but the adverse effects have not been systematically assessed. Our objective was to assess the beneficial and harmful effects of all...
6.
Juul S, Siddiqui F, Faltermeier P, Petersen J, Kamp C, Jakobsen R, et al.
Lancet Reg Health Eur
. 2024 Jul;
43:100993.
PMID: 39055683
No abstract available.
7.
Allott K, Pert A, Rattray A, Cooper R, Winther Davy J, Grunwald L, et al.
Psychiatr Rehabil J
. 2024 Jul;
47(4):291-302.
PMID: 39052404
Objective: To examine the evidence and practice of antipsychotic dose reduction from the lens of biomedical ethics (specifically principlism) to support evidence-based practice and patient choice and self-determination. Methods: An...
8.
Kendrick T, Stuart B, Bowers H, Haji Sadeghi M, Page H, Dowrick C, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2418383.
PMID: 38913372
Importance: There is significant concern regarding increasing long-term antidepressant treatment for depression beyond an evidence-based duration. Objective: To determine whether adding internet and telephone support to a family practitioner review...
9.
Horowitz M, Moncrieff J
Curr Opin Psychiatry
. 2024 May;
37(4):320-330.
PMID: 38726815
Purpose Of Review: There has been an increasing focus on deprescribing in psychiatry recently, particularly of antipsychotic medication, with recognition that not all patients with psychotic disorders require lifelong medication....
10.
Moncrieff J, Cooper R, Stockmann T, Amendola S, Hengartner M, Horowitz M
Mol Psychiatry
. 2024 Feb;
29(1):206-209.
PMID: 38374359
No abstract available.